Huang Michael F.

Sr. VP of Clinical Development at SOLENO THERAPEUTICS INC

Sold, on record
$1.2M
Dollars the filings state
Form 4 sales
2
Latest Mar 27, 2026
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice SOLENO THERAPEUTICS INCNotice
    Mar 27, 2025 2025

    Filed to sell 29,625 shares ($1.5M)

    Huang Michael F., Officer

    No 10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale SOLENO THERAPEUTICS INCUnusual
    Mar 27, 2025 same day

    Sold 14,583 shares at $69.51 ($1M)

    Huang Michael F., Sr. VP of Clinical Development

    No 10b5-1 planSold 28.4% of holdings ($3.6M position)36,817 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 4 sale SOLENO THERAPEUTICS INCNo plan
    Mar 27, 2026 +365 days

    Sold 6,582 shares at $30.44 ($200k)

    Huang Michael F., Sr. VP of Clinical Development

    No 10b5-1 planSold 14.2% of holdings ($1.4M position)39,823 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Huang Michael F.
Source
Mar 27, 2026Mar 31, 2026SOLENO THERAPEUTICS INCSr. VP of Clinical DevelopmentForm 4 sale6,582$200k14.2%No planSEC
Mar 27, 2025Mar 31, 2025SOLENO THERAPEUTICS INCSr. VP of Clinical DevelopmentForm 4 sale14,583$1M28.4%UnusualSEC
Mar 27, 2025Mar 27, 2025SOLENO THERAPEUTICS INCOfficerForm 144 notice29,625$1.5MNoticeSEC